ID   ICR-SS-1
AC   CVCL_C6LR
DR   Wikidata; Q116049562
RX   PubMed=35954262;
CC   Characteristics: Established from the J000104314 xenograft maintained in NOD Scid gamma mice.
CC   Doubling time: 93 hours (PubMed=35954262).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=35954262).
CC   Omics: Deep quantitative proteome analysis.
CC   Derived from site: In situ; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): PubMed=35954262
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D18S51: 12,15
ST   D19S433: 13,15
ST   D21S11: 29,31.2
ST   D2S1338: 20,23
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 7,8
ST   D8S1179: 13
ST   FGA: 24
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
RX   PubMed=35954262; DOI=10.3390/cells11152418; PMCID=PMC9368503;
RA   Kerrison W.G.J., Ning J., Krasny L., Arthur A., Guljar N., Elms M.L.,
RA   Swain A., Jones R.L., Thway K., Huang P.H.;
RT   "Characterisation of a novel cell line (ICR-SS-1) established from a
RT   patient-derived xenograft of synovial sarcoma.";
RL   Cells 11:2418.1-2418.15(2022).
//